Medical devices, healthcare technology and the business of care
PMA approval · P200020

SBL-3 Multifocal Intraocular Lens

Lenstec, Inc. · Decision date Jul 22, 2022

FDA DECISIONP200020

What did the FDA approve?

FDA records P200020 as an original PMA application. The recorded decision is approval, dated Jul 22, 2022.

FDA approval order statement

Approval for the Lenstec SBL-3 Multifocal Intraocular Lens. This Lenstec SBL-3 Multifocal Intraocular Lens is indicated for primary implantation for the visual correction of aphakia, in adult patients with 1 diopter or less of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing a bifocal correction. Compared to an aspheric monofocal IOL, the lens provides improved near visual acuity, while maintaining comparable distance and intermediate visual acuity. The lens promotes the less frequent use of vision correction choices at near distance (including glasses, contact lenses, magnifying glasses, and digital adjustments on electronic devices), compared to an aspheric monofocal IOL, as reported in patient-reported outcomes. The SBL-3 multifocal IOL is intended for capsular bag placement only.
Regulatory pathway
Original PMA
Clinical specialty
Ophthalmic
Decision date
Jul 22, 2022

FDA source record

Regulatory record facts

Identifier
P200020
Regulatory pathway
Premarket approval application
Applicant
Lenstec, Inc.
Product code
MFK
Decision code
APPR
Decision date
Jul 22, 2022
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, multifocal intraocular.

Applicant
Lenstec, Inc.
Product code
MFK
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P200020 received

    Application receipt date recorded by FDA.

  2. P200020 · FDA decision

    APPR

  3. P200020/S013 · Related supplement

    ClearView HD intraocular lens (IOL)

Timeline entries are records held by MedtechLedger for P200020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200020

Product / regulatory recordCompanyPathwayDecision dateSource
Lenstec, Inc.PMA supplementOct 23, 2026FDA

Explore the linked device profile

Other records with product code MFK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Lenstec, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1765 Commerce Ave. N, St. Petersburg, FL, 33716

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records